Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,931 | 70,502 | 102,724 | 160,754 | 71,764 |
| Marketable Securities | 483,946 | 514,800 | 321,212 | 380,560 | 245,238 |
| Receivables | 15,319 | 10,442 | 3,670 | 8,314 | 11,599 |
| Inventories | 7,331 | 869 | N/A | N/A | N/A |
| TOTAL | $611,704 | $613,780 | $445,261 | $559,892 | $337,329 |
| Non-Current Assets | |||||
| PPE Net | 31,472 | 24,320 | 24,431 | 25,337 | 23,220 |
| Investments And Advances | 152,929 | 220,119 | 143,814 | 32,250 | 58,905 |
| Other Non-Current Assets | 94,636 | 238 | 891 | 1,615 | 611 |
| TOTAL | $279,037 | $244,677 | $169,136 | $59,202 | $82,736 |
| Total Assets | $890,741 | $858,457 | $614,397 | $619,094 | $420,065 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,896 | 17,880 | 22,767 | 17,106 | 14,748 |
| Accrued Expenses | 53,142 | 42,147 | 34,031 | 32,002 | 15,996 |
| TOTAL | $92,886 | $93,503 | $94,941 | $88,433 | $52,888 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,933 | 33,476 | 38,143 | 39,325 | 22,144 |
| Other Non-Current Liabilities | 106,074 | 0 | 0 | 0 | 0 |
| TOTAL | $157,327 | $77,417 | $143,953 | $172,070 | $22,059 |
| Total Liabilities | $250,213 | $170,920 | $238,894 | $260,503 | $74,947 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,514 | 58,395 | 57,327 | 42,234 | 37,851 |
| Common Shares | 68 | 58 | 49 | 42 | 38 |
| Retained earnings | -1,516,105 | -1,104,633 | -798,061 | -483,151 | -284,680 |
| Other shareholders' equity | 202 | -2,171 | -1,389 | -313 | -318 |
| TOTAL | $640,528 | $687,537 | $375,503 | $358,591 | $345,118 |
| Total Liabilities And Equity | $890,741 | $858,457 | $614,397 | $619,094 | $420,065 |